Advertisement
New Zealand markets closed
  • NZX 50

    11,744.39
    +2.92 (+0.02%)
     
  • NZD/USD

    0.6113
    +0.0025 (+0.42%)
     
  • NZD/EUR

    0.5629
    -0.0001 (-0.01%)
     
  • ALL ORDS

    8,007.10
    +47.60 (+0.60%)
     
  • ASX 200

    7,745.60
    +46.90 (+0.61%)
     
  • OIL

    79.81
    +1.55 (+1.98%)
     
  • GOLD

    2,091.60
    +36.90 (+1.80%)
     
  • NASDAQ

    18,302.91
    +259.06 (+1.44%)
     
  • FTSE

    7,682.50
    +52.48 (+0.69%)
     
  • Dow Jones

    39,087.38
    +90.99 (+0.23%)
     
  • DAX

    17,735.07
    +56.88 (+0.32%)
     
  • Hang Seng

    16,589.44
    +78.00 (+0.47%)
     
  • NIKKEI 225

    39,910.82
    +744.63 (+1.90%)
     
  • NZD/JPY

    91.6610
    +0.4010 (+0.44%)
     

2 Best Medical Device Stocks for 2023

2 Best Medical Device Stocks for 2023

Over the past five years, for instance, industry giants like Medtronic have lagged the broader markets from a capital appreciation standpoint due to headwinds emanating from legacy portfolios, while up-and-coming device makers such as the diabetes care company DexCom have yielded life-changing gains for shareholders. Armed with this background, I think the diabetes care specialist Insulet (NASDAQ: PODD) and the surgical device company Conmed (NYSE: CNMD) are poised to be medtech's two best performers in 2023. The diabetes care specialist Insulet has been a rare bright spot in the medtech stock space in 2022.